MEDICAL TECHNOLOGY M&A MARKET DYNAMICS
- M&A activity in the Medical Technology sector was relatively soft in Q1 2025, with 118 announced transactions, falling short of the 135 deals recorded in Q1 2024. To keep pace with the relatively stable deal volumes seen over the past three years on a yearly basis, the market will need to see a pickup in activity in the coming quarters.
- Continuing with historical norms, strategic buyers accounted for approximately two-thirds of Medical Technology deals in the quarter, with 78 transactions.
- Deals were well-distributed across segments, with the Consumable & Disposable sector leading at 20% of total transactions. The Equipment, Service, and Therapeutic Devices segments accounted for 18%, 18%, and 14% of the activity, reflecting a balanced investment landscape.
Medical Technology M&A Pulse – Q3 2025
M&A activity in the Medical Technology sector remained subdued in Q3 2025 at 102 announced transactions, significantly below the 165 deals recorded in Q3 2024.
Medical Technology M&A Pulse – Q2 2025
M&A activity in the Medical Technology sector remained subdued in Q2 2025, with 104 announced transactions, a decline from the 128 deals recorded in Q2 2024.
Medical Technology M&A Pulse – Q4 2024
MedTech M&A deal volume in 2024 remained consistent with 2023 levels despite headwinds from rising input costs and regulatory shifts over the past year.
Medical Technology M&A Pulse – Q3 2024
Interest rate cuts bring a breath of fresh air to the Medical Technology sector, as more capital becomes available for acquisitions.
Medical Technology M&A Pulse – Q2 2024
Ongoing volatility in the Medical Technology M&A sector is driving heightened diligence and investor scrutiny to ensure acquisition targets are high-quality assets capable of withstanding current market turbulence.